Peptides as NS3-serine protease inhibitors of hepatitis C virus

摘要

Peptides of formula (I) as NS3-serine protease inhibitors of hepatitis C virus that have HCV protease inhibitory activity and methods for preparing these peptide compounds are disclosed, wherein the variables are as defined in the specification. Pharmaceutical compositions comprising these compounds that are useful for treating disorders associated with the HCV protease are also disclosed.